Biotech company pushes development of hydrogel-based wound product

10/8/2013 | PharmaBiz.com (India)

Biotechnology company BioTime has begun pre-approval testing of a wound dressing based on cross-linked thiol-modified hyaluronan and thiol-modified gelatin. The product maintains a moist wound bed, and a biodegradable matrix serves as a scaffold for cellular infiltration and capillary growth. If approved, the product may provide a foundation for bioactive wound care products that deliver biological factors or cells.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY